Free Trial

Integer (ITGR) Competitors

Integer logo
$121.80 +1.33 (+1.10%)
Closing price 03:59 PM Eastern
Extended Trading
$121.80 +0.01 (+0.00%)
As of 04:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ITGR vs. BDSX, ELV, BAX, HOLX, MASI, GMED, TFX, ATEC, ATRC, and IART

Should you be buying Integer stock or one of its competitors? The main competitors of Integer include Biodesix (BDSX), Elevance Health (ELV), Baxter International (BAX), Hologic (HOLX), Masimo (MASI), Globus Medical (GMED), Teleflex (TFX), Alphatec (ATEC), AtriCure (ATRC), and Integra LifeSciences (IART). These companies are all part of the "medical" sector.

Integer vs. Its Competitors

Biodesix (NASDAQ:BDSX) and Integer (NYSE:ITGR) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, profitability, risk and institutional ownership.

Biodesix has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500. Comparatively, Integer has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500.

Biodesix presently has a consensus price target of $1.75, suggesting a potential upside of 473.02%. Integer has a consensus price target of $145.00, suggesting a potential upside of 19.05%. Given Biodesix's higher probable upside, equities analysts clearly believe Biodesix is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biodesix
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Integer
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.00

Integer has a net margin of 4.38% compared to Biodesix's net margin of -54.28%. Integer's return on equity of 11.95% beat Biodesix's return on equity.

Company Net Margins Return on Equity Return on Assets
Biodesix-54.28% -167.28% -39.96%
Integer 4.38%11.95%6.04%

21.0% of Biodesix shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 30.1% of Biodesix shares are held by company insiders. Comparatively, 2.2% of Integer shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biodesix$71.32M0.63-$42.93M-$0.29-1.05
Integer$1.72B2.48$119.90M$2.1157.73

In the previous week, Integer had 2 more articles in the media than Biodesix. MarketBeat recorded 3 mentions for Integer and 1 mentions for Biodesix. Integer's average media sentiment score of 0.86 beat Biodesix's score of 0.00 indicating that Integer is being referred to more favorably in the news media.

Company Overall Sentiment
Biodesix Neutral
Integer Positive

Summary

Integer beats Biodesix on 15 of the 17 factors compared between the two stocks.

Get Integer News Delivered to You Automatically

Sign up to receive the latest news and ratings for ITGR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ITGR vs. The Competition

MetricIntegerMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$4.20B$6.75B$5.56B$20.59B
Dividend YieldN/A1.26%5.25%3.73%
P/E Ratio57.7319.1319.5826.08
Price / Sales2.4870.94442.2743.16
Price / Cash13.5220.8037.5022.41
Price / Book2.524.778.084.61
Net Income$119.90M$174.76M$3.16B$982.91M
7 Day Performance0.66%1.56%3.77%3.26%
1 Month Performance-0.62%0.58%3.90%4.37%
1 Year Performance6.23%15.23%34.22%14.95%

Integer Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ITGR
Integer
3.8138 of 5 stars
$121.80
+1.1%
$145.00
+19.0%
+4.7%$4.20B$1.72B57.7311,000News Coverage
BDSX
Biodesix
3.3956 of 5 stars
$0.28
+12.7%
$1.75
+520.1%
-80.5%$36.69M$71.32M-0.97220Positive News
ELV
Elevance Health
4.9681 of 5 stars
$389.42
+2.1%
$498.87
+28.1%
-34.6%$86.19B$177.01B15.19104,200Trending News
Upcoming Earnings
Analyst Forecast
BAX
Baxter International
4.2636 of 5 stars
$30.33
-0.2%
$37.25
+22.8%
-12.2%$15.60B$10.64B-27.5738,000Analyst Forecast
HOLX
Hologic
4.7715 of 5 stars
$65.16
+0.2%
$77.42
+18.8%
-11.9%$14.49B$4.03B27.497,063News Coverage
Positive News
Analyst Forecast
MASI
Masimo
3.7389 of 5 stars
$168.22
+0.0%
$191.60
+13.9%
+54.7%$9.12B$2.09B-18.345,600News Coverage
GMED
Globus Medical
4.9522 of 5 stars
$58.98
+0.6%
$94.00
+59.4%
-16.2%$7.93B$2.52B44.015,300
TFX
Teleflex
4.7284 of 5 stars
$118.21
-1.1%
$164.63
+39.3%
-45.5%$5.28B$3.05B37.2914,100Positive News
ATEC
Alphatec
4.3995 of 5 stars
$11.10
+0.2%
$17.89
+61.2%
+6.0%$1.62B$611.56M-9.65700
ATRC
AtriCure
3.4193 of 5 stars
$32.77
+1.5%
$50.67
+54.6%
+43.5%$1.60B$465.31M-40.461,300Positive News
IART
Integra LifeSciences
4.082 of 5 stars
$12.27
-0.2%
$18.63
+51.8%
-55.0%$955.08M$1.61B-32.294,396

Related Companies and Tools


This page (NYSE:ITGR) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners